Related by context. All words. (Click for frequent words.) 71 methacholine 69 timepoints 67 bronchial hyperresponsiveness 67 leukocyte count 66 electrophysiologic 66 posttreatment 66 serum cortisol 66 exhaled nitric oxide 66 postintervention 66 spirometric 65 intact parathyroid hormone 65 mL/min/#.# m 2 65 intima media thickness 65 pulmonary arterial 65 CI -#.# 65 HER2 expression 65 primary aldosteronism 65 urine cytology 65 euthyroid 65 clomipramine 65 glomerular filtration 64 vasopressor 64 airway hyperresponsiveness 64 eNO 64 WOMAC pain 64 serum TSH 64 MMSE score 64 Secondary endpoints included 64 symptomatic VTE 64 β blockers 64 induced sputum 64 colorectal adenoma 64 Primary endpoints 64 CYP#D# inhibitor 64 urodynamic 64 p = .# [002] 64 paricalcitol 64 multivariate analyzes 64 serum IgE 64 urine albumin 64 hemodynamic variables 63 achieved statistical significance 63 antibody titer 63 #.#/#.# mmHg [001] 63 Insulin sensitivity 63 airway responsiveness 63 LV dysfunction 63 Subgroup analysis 63 CTEPH 63 endometrial thickness 63 SGPT 63 aPTT 63 urinary sodium excretion 63 prostate cancer CaP 63 HAQ DI 63 baroreceptor 63 adenotonsillectomy 63 dose dependently 63 carotid IMT 63 abnormal cytology 63 μg kg 63 troponin T 63 tryptase 63 Crohn Disease Activity 63 locomotor activity 63 CC genotype 63 haematologic 63 thyroid stimulating hormone 63 salivary cortisol 63 liver histology 63 posttransplant 63 % CI #.#-#.# [003] 63 isoprostane 63 morphometric vertebral fractures 63 brachial artery flow 62 fasting plasma 62 aspartate aminotransferase AST 62 mL kg 62 #mg/day [001] 62 pyridostigmine 62 eosinophil count 62 HOMA IR 62 corrected QT interval 62 intratympanic 62 pentoxifylline 62 statistically significant p = 62 -#.# ± [002] 62 asthma exacerbation 62 GH deficiency 62 cardiac autonomic 62 P = .# 62 postoperative complication 62 OGTT 62 NIHSS 62 coronary stenosis 62 pharmacokinetic parameters 62 hematological parameters 62 dyspnoea 62 electrical cardioversion 62 pmol L 62 NIH CPSI 62 genotypic resistance 62 attain statistical significance 62 sub maximal 62 SGRQ 62 clinically meaningful improvements 62 nondiabetic patients 62 chest radiographs 62 transthoracic 62 hyperalgesia 62 endothelium dependent 62 Index CDAI 62 lavage fluid 62 methotrexate monotherapy 62 rt PA 62 #ng/ml 62 AST ALT 62 PSA nadir 62 HBeAg negative patients 62 severe exacerbations 62 HDRS 61 ejection fractions 61 plasma pharmacokinetics 61 echocardiographic 61 bronchodilatory 61 perioperatively 61 radiographic progression 61 chemoradiation therapy 61 undetectable HBV DNA 61 bronchial reactivity 61 intraobserver 61 specific antigen PSA 61 atrial pacing 61 abacavir lamivudine 61 tracheal intubation 61 enzyme inhibition 61 serum concentrations 61 lactate dehydrogenase 61 tumor histology 61 F FDG PET 61 tissue oxygenation 61 alanine aminotransferase ALT 61 Visual Analogue Scale VAS 61 CCyR 61 clinically meaningful improvement 61 salmeterol fluticasone 61 intravenous dosing 61 budesonide pMDI 61 clinicopathological 61 UGT#A# * 61 μmol L 61 adrenocortical 61 angiotensin converting enzyme 61 % CI #.#-#.# [007] 61 NYHA functional class 61 histologic subtype 61 Tasigna prolongs 61 CK MB 61 bronchoalveolar lavage fluid 61 dobutamine 61 apolipoprotein B 61 mcg BID 61 Qmax 61 expiratory 61 test OGTT 61 anterior temporal 61 ginkgo extract 61 conditional logistic regression 61 nasal symptom 61 ATACAND 61 monoinfected patients 61 eplerenone 61 atorvastatin #mg 61 polytherapy 61 nadroparin 61 renal cysts 61 thyroglobulin 61 Secondary endpoints 61 timepoint 61 HbA 1c 61 multivariable analyzes 61 Histologic 61 intravitreal injections 61 creatine kinase 61 peak VO2 61 microdose 61 cefotaxime 61 daily subcutaneous injections 61 sodium nitroprusside 61 db db mice 61 albumin excretion rate 61 immunostaining 61 hemodilution 61 VCUG 61 allergic airway inflammation 61 normoxic 61 QTcF 61 fasting glucose levels 61 ALT normalization 60 HepG2 cells 60 detrusor overactivity 60 fluticasone salmeterol 60 pg ml 60 ropivacaine 60 left ventricular systolic 60 metabolite concentrations 60 hemoglobin hematocrit 60 metabolic parameters 60 dose proportionality 60 mIU L 60 semiquantitative 60 monophasic 60 adjuvant cisplatin 60 DFMO 60 d dimer 60 multivariate Cox 60 nonobese 60 Score DAS# 60 BPS IC 60 intravenous cyclophosphamide 60 thyrotropin 60 LV ejection fraction 60 cranial irradiation 60 maximal aerobic capacity 60 airway narrowing 60 Subgroup analyzes 60 creatinine levels 60 desvenlafaxine succinate 60 leflunomide 60 mediated dilation 60 normotensive 60 hemoglobin Hb 60 cilostazol 60 recurrent glioblastoma multiforme 60 pg mL 60 experimentally induced 60 pCR 60 plasma cortisol 60 microsatellite instability 60 nicardipine 60 transabdominal 60 artery stenosis 60 mm Hg diastolic 60 preoperative PSA 60 ventricular tachyarrhythmia 60 plasma folate 60 pretransplant 60 ACTH 60 IOP lowering 60 anagrelide 60 bronchoalveolar lavage 60 plasma renin activity 60 hMG 60 biochemical relapse 60 Secondary efficacy endpoints 60 multivariate logistic regression 60 glycated hemoglobin levels 60 lactulose 60 oral glucose tolerance 60 somatostatin analog 60 reactogenicity 60 sweat chloride 60 MR spectroscopy 60 exhaled NO 60 multiple logistic regression 60 adenoma recurrence 60 interquartile range 60 mL/min/#.# m2 60 glycosylated hemoglobin HbA1c 60 hyperresponsiveness 60 chloride secretion 60 HER2 amplification 60 hypothalamic pituitary adrenal axis 60 postprocedure 60 neutrophil counts 60 myeloperoxidase 60 #OHD 60 tipranavir ritonavir 60 6MWT 60 pulmonary artery pressure 60 NMES 60 CDAI 60 aspartate aminotransferase 60 phototoxicity 60 prolonged QT interval 60 erythropoietic 60 BMI z 60 ADAS Cog 60 left ventricular diastolic 60 CIMZIA TM certolizumab pegol 60 Plasma concentrations 60 inflammatory biomarkers 60 nerve conduction velocity 60 LDB CPR 60 triiodothyronine 60 postdose 60 MTHFR 60 perfusion MRI 60 racemic albuterol 60 nmol 60 autonomic dysfunction 60 inotropic agents 60 alteplase 60 Tg mice 60 postoperative AF 60 HIV HCV coinfected 60 ipsilateral stroke 60 coagulation parameters 60 PaO 2 60 arterial oxygen saturation 60 Secondary endpoints include 60 mg kg dose 59 HbA1C levels 59 polysomnogram 59 Brief Psychiatric 59 Y BOCS 59 micronuclei 59 ischemia induced 59 periprocedural 59 procalcitonin 59 CPAP adherence 59 underwent coronary angiography 59 TT genotype 59 oral rivaroxaban 59 virological response 59 ADCS CGIC 59 glomerular filtration rate 59 bronchoalveolar lavage BAL 59 specific IgE 59 mycophenolate mofetil MMF 59 metastatic malignant 59 CIN2 + 59 umol L 59 tolterodine ER 59 gross hematuria 59 extensive metabolizers 59 iloprost 59 serum retinol 59 serum thyroglobulin 59 PCWP 59 seropositivity 59 nonischemic 59 recombinant tissue plasminogen 59 monozygotic twin 59 univariate analyzes 59 histological subtype 59 logistic regression analysis 59 esophageal acid 59 lactate dehydrogenase LDH 59 achieved CCyR 59 nonobese patients 59 carotid stenosis 59 inducible nitric oxide synthase 59 glycated 59 reactive hyperemia 59 autoregulation 59 posttest 59 systemic corticosteroid 59 AGHD 59 Postoperative complications 59 MGd 59 culture supernatants 59 systemic hypotension 59 bronchoalveolar 59 angiographically 59 ABCB1 59 normal karyotype 59 #q# deletion syndrome 59 audiometric 59 elevated ALT 59 SSc 59 lumbar spine BMD 59 mRNA expression 59 Doxil ® 59 antiandrogens 59 flow mediated dilation 59 cortical activation 59 Cardiorespiratory fitness 59 μg liter 59 acromegalic patients 59 adrenalectomy 59 HLA DR4 59 neurocognitive function 59 confidence interval CI 59 #mmHg [001] 59 salmeterol fluticasone propionate 59 serum urate levels 59 ADAS cog 59 #ß 59 cystoscopic 59 noninferiority 59 apnea hypopnea index 59 preintervention 59 VKORC1 59 TNFalpha 59 -#.# log# copies mL 59 transcranial Doppler ultrasound 59 thorough QT 59 Skin sterol 59 HGPIN 59 antiarrhythmic medications 59 aromatase inhibitor therapy 59 serum estradiol 59 CsA 59 sonographically guided 59 mcg QD 59 POAG 59 akinesia 59 CP CPPS 59 fasting plasma glucose FPG 59 creatinine ratio 59 Doppler echocardiography 59 hepatic enzymes 59 cardiac troponin 59 Immunohistochemical analysis 59 serum antibody 59 vesicoureteral reflux 59 nadolol 59 multivariable analysis 59 8mg/kg 59 Kruskal Wallis test 59 bioavailable testosterone 59 lung resection 59 thyroid stimulating hormone TSH 59 pairwise comparisons 59 detrusor 59 #.#mmHg 59 S#A# [002] 59 acoustic startle 59 intracoronary 59 hematologic parameters 59 elevated transaminases 59 intravenous bolus 59 fluticasone furoate 59 microg 59 IELT 59 PsA 59 hyperphenylalaninemia HPA due 59 p = #.# [003] 59 maternal serum 59 cerebral angiography 59 oocytes retrieved 59 histopathological 59 periocular 59 advanced adenoma 59 Montgomery Åsberg Depression 59 lowest tertile 59 muscarinic receptors 59 epoetin alpha 59 cardiac repolarization 59 macrolide antibiotic 59 silent myocardial ischemia 59 serum BDNF 59 corticosteroid therapy 59 TMPRSS2 ERG 59 carotid artery thickness 59 IGFBP 3 59 QTc intervals 59 alanine aminotransferase 59 EQ 5D 59 6MWD 59 transrectal ultrasound guided 59 relapsed MM 59 HPA axis 59 urinary excretion 59 spontaneous bowel movements 59 serum bilirubin 59 Serum creatinine 59 hypothalamic pituitary 59 albumin excretion 59 serum testosterone 59 oral anticoagulation 59 crossclamp 59 nephrogenic 59 octreotide LAR 59 ANOVA 59 FENO 59 homozygotes 59 SpCO 59 oral antidiabetic medication 59 hsCRP levels 59 mdx mice 59 estimated glomerular filtration 59 HbF 59 steroidogenic 59 plasma creatinine 59 rtPA 59 cTnT 59 diuretic chlorthalidone 59 cytogenic 59 transdermal estradiol 59 bolus dose 59 ejection fraction EF 59 systolic dysfunction 59 mCi 59 hyperinsulinemic euglycemic clamp 59 thrombocytopenic 59 ob ob mice 59 chi squared 59 dyssynchrony 59 doxorubicin docetaxel 59 hepatic enzyme 59 abacavir Ziagen 59 adrenal function 59 cinacalcet 59 ROC curves 59 urothelial cancer 59 Serum concentrations 59 leukocyte counts 59 prolactin elevation 59 riociguat 59 postop 59 pharmacokinetic PK profile 59 overnight polysomnography 59 Symptom severity 59 myogenic 59 systolic function 59 scintigraphic 59 â ‰ ¥ 59 multivariable adjusted 59 nasal airflow 59 Solid Tumors criteria 59 serum urate 59 4mg/kg 59 PSADT 59 #mg doses [002] 58 DAS# remission 58 ertapenem 58 ug kg 58 #.#ng/ml 58 TOP2A 58 serum PSA 58 cerebral perfusion 58 tertile 58 interobserver reliability 58 NNT = 58 alpha1 antitrypsin deficiency 58 vasomotor 58 CLA supplementation 58 dose clopidogrel 58 calculated creatinine clearance 58 pharmacodynamic PD 58 intermittent dosing 58 corticotropin releasing hormone 58 hemodynamic parameters 58 mucosal healing 58 muscarinic receptor 58 leiomyomas 58 contractility 58 dosage regimens 58 guanfacine extended release 58 elevated creatinine 58 hippocampal volume 58 definite stent thrombosis 58 inotropic 58 androgen ablation 58 HRQL 58 IFN beta 58 nonsignificant difference 58 univariate analysis 58 sinus tachycardia 58 FDG PET imaging 58 montelukast 58 PKC inhibitors 58 carcinoembryonic antigen 58 GERD symptom 58 mutated K ras 58 exploratory endpoints 58 Perforomist Inhalation Solution 58 denervation 58 recurrent DVT 58 colorectal liver metastases 58 subcutaneous insulin 58 mg eq 58 surgical debulking 58 metastatic lymph nodes 58 MBq 58 Forced expiratory volume 58 dehydroepiandrosterone sulfate 58 baseline HbA1c 58 carotid bruit 58 tracer uptake 58 complete cytogenetic response 58 aminotransferases 58 serum bicarbonate 58 polysomnography PSG 58 prognostic significance 58 transcranial Doppler 58 caspofungin 58 pharmacokinetic characteristics 58 uM 58 HbA 1c levels 58 bivariate analysis 58 weekly subcutaneous injections 58 lipid parameters 58 bronchopulmonary dysplasia 58 jugular venous 58 airway hyper responsiveness 58 elastase 58 CT perfusion 58 vasodilatory 58 anemia hemoglobin 58 symptomatic intracranial 58 platelet reactivity 58 receptor blocker 58 fasting insulin 58 ischemic lesions 58 preterm neonates 58 HbA1C 58 amoxicillin clavulanate 58 conventional DMARDs 58 serum ferritin 58 crizotinib PF # 58 antithymocyte globulin 58 ALT flares 58 PASI scores 58 nerve conduction velocity NCV 58 paracentesis 58 epigastric pain 58 inhaled iloprost 58 cefazolin 58 SCIg 58 fluticasone propionate FP 58 histologic 58 hypertonic saline 58 nonvertebral fracture 58 corticosteroid dose 58 hypoxemia 58 FDG-PET/CT 58 rFSH 58 RECIST Response Evaluation Criteria 58 fluvastatin 58 ERalpha 58 diagnostic angiography 58 serum phosphorous 58 DAS# CRP 58 μg L 58 anthracycline chemotherapy 58 FDG uptake 58 pharmacodynamic effects 58 protein excretion 58 intravascular hemolysis 58 recurrent venous thromboembolism 58 nutlin 3a 58 mIU mL 58 Western blotting 58 Fibromyalgia Impact Questionnaire 58 parathyroidectomy 58 fetal malformations 58 thyrotropin levels 58 cTnI 58 Fasting glucose 58 BoNTA 58 intravenous IV infusion 58 atrioventricular block 58 serotonin synthesis 58 ritonavir boosted 58 pT3 58 steroid dexamethasone 58 serum calcium 58 LEXIVA r 58 placebo p = 58 plasma triglycerides 58 diabetic gastroparesis 58 mm Hg systolic 58 Apgar scores 58 erection hardness 58 umbilical artery 58 nmol liter 58 serum homocysteine 58 % CI #.#-#.# [001] 58 PNES 58 Multivariate analysis 58 TURBT 58 macroalbuminuria 58 comorbid anxiety 58 NIHSS score 58 Wistar rats 58 gadolinium enhanced 58 physiologic responses 58 selective modulator 58 myocardial contractility 58 serum leptin 58 fructose intolerance 58 T2 lesions 58 hemorrhagic complications 58 RVOT 58 HRCT 58 BPH symptom 58 CIN3 58 activated partial thromboplastin 58 bezafibrate 58 pretest probability 58 IFN γ 58 NF kappaB activation 58 vasoactive 58 intracerebral 58 supraventricular 58 Score TOS 58 GG genotype 58 T1DM 58 tumorigenicity 58 salivary flow 58 unresectable HCC 58 postprandial glucose 58 multivariable Cox 58 diastolic function 58 NSCLC tumors 58 systemic corticosteroids 58 biphasic 58 #OHD levels 58 rCBF 58 prospectively defined 58 audiometry 58 serum HBV DNA 58 pretreatment baseline 58 preoperative chemotherapy 58 plasma leptin 58 rheumatoid factor 58 perioperative complications 58 ng dl 58 subcutaneous enoxaparin 58 MDS MPD 58 pituitary hormone 58 cerebrovascular accidents 58 ventilatory 58 estrogen metabolites 58 cerebral oxygenation 58 E selectin 58 TOP2A gene 58 lymphocyte count 58 = #.#-#.# 58 irbesartan 58 sonographic diagnosis 58 overactive bladder symptoms 58 BMPR2 58 SSRI citalopram 58 tertiles 58 intestinal mucosal 58 Non inferiority 58 Neuropsychiatric Inventory NPI 58 placebo p 58 pelvic lymphadenectomy 58 cortical atrophy 58 hemoglobin A1c HbA1c 58 SERCA2a 58 rs# [004] 58 LDL HDL 58 edifoligide 58 pulmonary angiography 58 fructosamine 58 electroencephalographic 58 patients undergoing CABG 58 glutamic acid decarboxylase 58 Thrombolysis 58 humoral responses 58 IgA deficiency 58 zoledronate 58 MetS 58 CD# expression [002] 58 trials RCTs 58 chemosensitivity 58 lesional 58 euthymic patients 58 intraoperative complications 58 HBeAg seroconversion 58 antiretroviral naïve 58 Cmax 58 tirofiban 58 chlamydial infection 58 leptin deficient mice 58 cerebral oxygen saturation 58 APOE e4 58 QRS duration 58 mucociliary clearance 58 binary restenosis 58 dosing cohort 58 pharmacodynamic endpoints 58 leukocytosis 58 antibody mediated 58 tumor necrosis 58 #mg BID [003] 58 covariate 58 PEG IFN 58 microcirculatory 58 inhaled budesonide 58 prospectively evaluated 58 F FDG uptake 58 left ventricular LV 58 plasma renin 58 submaximal exercise 58 plus medroxyprogesterone acetate 58 logistic regression model 58 immunoblot 58 oncologic outcomes 58 ovarian carcinoma 58 trough FEV1 58 serum lactate 58 IL6 58 gastro esophageal reflux 58 plus methotrexate 57 SUVmax 57 luteal 57 histologic findings 57 noncardiac 57 serum IgG 57 chromosomal aberrations 57 nasal obstruction 57 beta blocker therapy 57 pulmonary resection 57 platelet dysfunction 57 extrapyramidal symptoms 57 serum triglycerides 57 deoxy 57 symptom exacerbation 57 nonpregnant women 57 mg/m2 dose 57 HCV antibody 57 oxycodone CR 57 RRM1 57 carotid plaque 57 logistic regression analyzes 57 microdialysis 57 SOD2 gene 57 abdominal subcutaneous fat 57 immunohistochemical analysis 57 prospectively stratified 57 serum potassium 57 argatroban 57 lymphocyte counts 57 baseline Hb 57 Univariate analysis 57 capillary density 57 biochemical abnormalities 57 gene polymorphisms 57 beclomethasone dipropionate 57 ventricular dilatation 57 bortezomib refractory 57 TPMT 57 RoACTEMRA 57 antihypertensive therapy 57 intraventricular 57 serum calcium levels 57 Psoriasis Area 57 dalteparin 57 PLX STROKE targeting 57 potentiation 57 mmHg diastolic 57 radiotherapy RT 57 thyroid hormone levels 57 GnRH agonist 57 μg d 57 endogenous opioid 57 overt nephropathy 57 biochemical recurrence 57 aminotransferase 57 degranulation 57 INVEGA ® 57 NAbs 57 dysuria 57 transvaginal sonography 57 Health Assessment Questionnaire 57 serum uric acid 57 bolus injection 57 iPTH 57 dopamine reuptake 57 solifenacin 57 beta2 agonist 57 serum prostate 57 ketorolac 57 endothelial activation 57 Rating Scale MADRS 57 Ki# 57 fosbretabulin 57 microvessel density 57 electrophysiological 57 Kaplan Meier analysis 57 upper gastrointestinal bleeding 57 GH secretion 57 hypoxia induced 57 IFN α 57 PRADAXA #mg 57 esophageal pH 57 pleurodesis 57 pulmonary exacerbation 57 5mg dose 57 hsCRP 57 retrograde ejaculation 57 squamous intraepithelial lesions 57 pulmonary function 57 prostate carcinoma 57 lupus anticoagulant 57 confidence intervals CIs 57 Bonferroni 57 cough dyspnea 57 headache nasopharyngitis 57 carotid intima media 57 hepatorenal syndrome 57 Hypotension 57 vasodilatation 57 isoproterenol 57 paroxysmal AF 57 troponins 57 cis retinoic acid 57 systolic hypertension 57 DAS# [002] 57 sodium excretion 57 extubation 57 peri procedural 57 viral titers 57 Myoglobin 57 iNO 57 miRNA expression 57 atrioventricular valve 57 gene polymorphism 57 urinary N telopeptide 57 FDA defined valvulopathy 57 chronic thromboembolic pulmonary 57 apolipoproteins 57 glycated hemoglobin HbA1c 57 meta regression 57 idraparinux 57 ^ sup #m 57 intravenous tissue plasminogen 57 C#BL/#J mice 57 cerebral infarction 57 Kaplan Meier curves 57 immunohistochemical 57 intravesical therapy 57 preeclamptic 57 QT QTc 57 acylated ghrelin 57 K ras mutations 57 LNG IUS 57 urate lowering therapy 57 reintubation 57 sonographically 57 #μg [002] 57 PCa 57 antioxidant supplementation 57 atopic asthma 57 antiarrhythmic drug 57 min -1 57 nociceptive 57 SHBG levels 57 C telopeptide 57 transgene expression 57 serum phosphate 57 antiemetics 57 endometrial hyperplasia 57 sensory neuropathy 57 pulsatility index 57 lymphocytosis 57 EDSS score 57 pericardial effusion 57 clinicopathologic 57 mesalamine granules 57 sulphonylureas 57 analgesic efficacy 57 glucocorticoid induced 57 RAPAFLO R 57 pre eclamptic 57 anti arrhythmic drug 57 Cystatin C 57 ml min 57 azacytidine 57 radical retropubic prostatectomy 57 IL 1ß 57 serum aminotransferase levels 57 immunoreactivity 57 mucosal inflammation 57 pretreatment serum 57 percutaneous vertebroplasty 57 NMIBC 57 viral kinetics 57 VerifyNow 57 cortical stimulation 57 lispro 57 surgically induced 57 alkaline phosphatase 57 serum lipid levels 57 hemoglobin A1c levels 57 ultrasonographic examination 57 confidence interval #.#-#.# 57 LPS induced 57 μg ml 57 HCV replicon 57 immunohistochemical staining 57 genotoxicity 57 CIMZIA ™ 57 #mmHg [002] 57 orthostatic 57 hypogonadal men 57 ANCOVA 57 ovarian malignancy 57 radioimmunoassay 57 VaD 57 periventricular leukomalacia 57 nodal metastasis